Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Assets Average (2022 - 2025)

Historic Assets Average for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $245.3 million.

  • Phathom Pharmaceuticals' Assets Average fell 3056.41% to $245.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.3 million, marking a year-over-year decrease of 3056.41%. This contributed to the annual value of $396.1 million for FY2024, which is 3689.75% up from last year.
  • Per Phathom Pharmaceuticals' latest filing, its Assets Average stood at $245.3 million for Q3 2025, which was down 3056.41% from $272.2 million recorded in Q2 2025.
  • Over the past 5 years, Phathom Pharmaceuticals' Assets Average peaked at $385.2 million during Q1 2024, and registered a low of $154.4 million during Q1 2023.
  • Over the past 4 years, Phathom Pharmaceuticals' median Assets Average value was $261.6 million (recorded in 2023), while the average stood at $272.9 million.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 14944.66% in 2024, then plummeted by 3056.41% in 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' Assets Average (Quarter) stood at $183.4 million in 2022, then skyrocketed by 77.46% to $325.4 million in 2023, then grew by 17.6% to $382.7 million in 2024, then crashed by 35.91% to $245.3 million in 2025.
  • Its last three reported values are $245.3 million in Q3 2025, $272.2 million for Q2 2025, and $336.3 million during Q1 2025.